2021 GA Meeting May 12th, 14:00-15:30



The 2020 GA meeting which normally takes place in May was postponed to November 4th due to the global pandemic. The November 4th meeting which was virtual saw 20 attendees and lasted an hour as most of the GA mandated task/decisions were addressed by way of votes prior to the meeting. Chaired by Interim Chairman Dr Bernd Friede, the meeting though brief was effective with some key decisions taken as follows:

Some highlights:

  • Executive Committee: A new Executive team was endorsed with the 2nd Vice-Chairman becoming the Chairman and Secretary General maintained to ensure continuity
  • Non-EU letter of Access Fees: Letter of Access fees and administration fees for non-EU REACH-Like regulations per substance, per legal entity for non-MARA members was established
  • Members involvement in Non-EU regulations: MARA members wishing to register substances in non-EU REACH-like regulations will only pay administration fees as they own the data generated by MARA
  • Technical update: Three dossiers updated this year lead to a new classification for manganese based UVCB’s
  • 2020 Workplan and budget were ratified in Q1, 2020 via round robin votes.


Whether you are active in Europe now, or wish to be active in Europe in the future, REACH has to be a key element of your overall market strategy.

The REACH Mn Consortium was formed in January 2008 after considerable effort and input from its founding members. As a voluntary consortium an open invitation to join is extended to all organisations involved in the manganese industry worldwide.

Our Objectives:

With the active involvement of its membership the REACH Mn Consortium aims to:

  1. Evaluate existing data for relevant substances and highlight data gaps
  2. Jointly agree and initiate any necessary testing programmes
  3. Promote and manage the sharing of technical resources and knowledge
  4. Share its knowledge and support its members with the appropriate training on REACH and GHS
  5. Secure access to laboratory capacity and regulatory skills through agreements with contract testing service providers
  6. Have the registration dossier ready for submission before the end of November 2010
  7. Support the nominated lead registrant(s) for the relevant substances to submit the full registration dossier
  8. Manage and coordinate the whole process in a structured and cost effective way to ensure each member fulfils their REACH obligations on time


Compliance with REACH entails a wide range of responsibilities, liabilities, and costs. Individual organisations are unlikely to have the resources to fulfil all their REACH obligations in time by "going it alone." Instead, REACH encourages collaboration between importers and manufacturers of the same substance in order to meet their individual REACH responsibilities in a timely, efficient, and cost effective way. The formation of a voluntary consortium is an effective forum within which to realise this ambition.

About cookies on our website

Following a revised EU directive on website cookies, each company based, or doing business, in the EU is required to notify users about the cookies used on their website.

Our site uses cookies to improve your experience of certain areas of the site and to allow the use of specific functionality like social media page sharing. You may delete and block all cookies from this site, but as a result parts of the site may not work as intended.

To find out more about what cookies are, which cookies we use on this website and how to delete and block cookies, please see our Which cookies we use page.

Click on the button below to accept the use of cookies on this website (this will prevent the dialogue box from appearing on future visits)